Results 31 to 40 of about 145,320 (184)

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. [PDF]

open access: yesPLoS ONE, 2013
The data were presented in abstract form at the 45(th) meeting of the American Society of Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating autoantibodies against M-type phospholipase A2 receptor (PLA2R) are important pathogenic ...
Yun Jung Oh   +4 more
doaj   +1 more source

Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria

open access: yesScientific Reports, 2023
Patients with diabetes mellitus complicated with proteinuria can be diabetic nephropathy (DN), diabetic complicated with non-diabetic kidney disease (NDKD), or DN with NDKD.
Huanhuan Zhang   +3 more
doaj   +1 more source

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

open access: yesEuropean Journal of Medical Research, 2023
Background Most primary membranous nephropathy (MN) is mediated by anti-phospholipase A2 receptor (PLA2R) antibodies. Recently, these antibodies have been revealed months to years before the disease's onset.
Yan-jiao Cheng   +4 more
doaj   +1 more source

Posttransplant membranous nephropathy - A case report

open access: yesIndian Journal of Transplantation, 2022
Primary membranous nephropathy (PMN) is a common cause of adult-onset nephrotic syndrome. Anti-M-type phospholipase A2 receptor (PLA2R) antibodies are pathogenic and correlate with clinical outcomes. The role of anti-PLA2R in recurrent PMN is unclear. In
Shabna Sullaiman   +11 more
doaj   +1 more source

Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy [PDF]

open access: yesMedical Science Monitor, 2016
BACKROUND ~This study used two standardized methods to evaluate anti-PLA2R antibody in serum of primary membranous nephropathy (PMN) among Chinese patients to determine  Anti-PLA2R antibody distribution and whether immunological reactivity reflected by antibody titer correlates with kidney function parameters.
Li, Xin   +8 more
openaire   +2 more sources

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

open access: yesImmunological Medicine, 2020
Associations between anti-M-type phospholipase A2 receptor (PLA2R) antibodies and disease activity and prognosis have been suggested in primary membranous nephropathy (MN); however, more evidence is needed.
Yasuhiro Katsumata   +8 more
doaj   +1 more source

The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2022
Background/Aims Anti-phospholipase A2 receptor (PLA2R) autoantibody is the main biomarker of idiopathic membranous nephropathy (IMN). We aimed to find a new cutoff value of anti-PLA2R for patients with IMN and to explore the relevance between this ...
Chaofan Li   +6 more
doaj   +1 more source

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis

open access: yesBMC Nephrology, 2019
Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R) expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of patients with idiopathic membranous nephropathy (IMN). Methods A literature search
Dan Dong   +5 more
doaj   +1 more source

Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report [PDF]

open access: yesAmerican Journal of Kidney Diseases, 2016
There is little information about pregnancy outcomes in patients with active membranous nephropathy (MN), especially those with circulating autoantibodies to M-type phospholipase A₂receptor (PLA₂R), the major autoantigen in primary MN. We present what we believe to be the first known case of successful pregnancy in a 39-year-old woman with PLA₂R ...
Laith, Al-Rabadi   +7 more
openaire   +2 more sources

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

open access: yesBMC Nephrology, 2022
Background Idiopathic membranous nephropathy (iMN) is recognized as an organ-specific autoimmune disease, mainly caused by anti-PLA2R antibody. This study aimed to study between anti-PLA2R antibody level at diagnosis and the response to tacrolimus (TAC ...
Bihua Wang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy